URMC / Research / Clinical Trials / Study Details ULEU07047 / RSRB20123 / Michael Becker Basic Study Information Purpose:This study is being performed to develop assays to determine the impact of the therapy patients receive for treatment of AML or MDS and to determine if these tests can identify those patients who are at a greater risk for having their disease relapse. Location: University of Rochester Medical CenterLead Researcher (Principal Investigator) Lead Researcher: Michael Becker, MD Study Contact InformationStudy Coordinator: Amber JohnsonEmail: amber_johnson@urmc.rochester.edu Additional Study Details URMC / Wilmot Cancer Institute /Research / Clinical Trials / Study Details Trial Not Found The study you are looking for is not active at this time. Return to Search